TP53 and cancer: Interestingly, our results showed that ectopic BRIX1 dramatically reduced the expression of p53 protein (Figure 4A,B) and its target genes (Figure 4C,D) in cancer cells when treated with a low dose of Act D, as well as upon the treatment with DDP or 5‐FU (Figure S3C,D, Supporting Information).